Your browser doesn't support javascript.
loading
PKA signaling drives mammary tumorigenesis through Src.
Beristain, A G; Molyneux, S D; Joshi, P A; Pomroy, N C; Di Grappa, M A; Chang, M C; Kirschner, L S; Privé, G G; Pujana, M A; Khokha, R.
Afiliação
  • Beristain AG; Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Molyneux SD; 1] Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Joshi PA; 1] Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Pomroy NC; Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Di Grappa MA; Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada.
  • Chang MC; Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
  • Kirschner LS; Division of Endocrinology, Diabetes and Metabolism, The Ohio State University, Columbus, OH, USA.
  • Privé GG; Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada.
  • Pujana MA; Breast Cancer and Systems Biology Unit, Translational Research Laboratory, Catalan Institute of Oncology, IDIBELL, L'Hospitalet del Llobregat, Barcelona, Spain.
  • Khokha R; 1] Ontario Cancer Institute, Princess Margaret Hospital, Toronto, Ontario, Canada [2] Department of Medical Biophysics, University of Toronto, Toronto, Ontario, Canada [3] Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, Ontario, Canada.
Oncogene ; 34(9): 1160-73, 2015 Feb 26.
Article em En | MEDLINE | ID: mdl-24662820
ABSTRACT
Protein kinase A (PKA) hyperactivation causes hereditary endocrine neoplasias; however, its role in sporadic epithelial cancers is unknown. Here, we show that heightened PKA activity in the mammary epithelium generates tumors. Mammary-restricted biallelic ablation of Prkar1a, which encodes for the critical type-I PKA regulatory subunit, induced spontaneous breast tumors characterized by enhanced type-II PKA activity. Downstream of this, Src phosphorylation occurs at residues serine-17 and tyrosine-416 and mammary cell transformation is driven through a mechanism involving Src signaling. The phenotypic consequences of these alterations consisted of increased cell proliferation and, accordingly, expansion of both luminal and basal epithelial cell populations. In human breast cancer, low PRKAR1A/high SRC expression defines basal-like and HER2 breast tumors associated with poor clinical outcome. Together, the results of this study define a novel molecular mechanism altered in breast carcinogenesis and highlight the potential strategy of inhibiting SRC signaling in treating this cancer subtype in humans.
Assuntos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Quinases da Família src / Subunidade RIalfa da Proteína Quinase Dependente de AMP Cíclico / Glândulas Mamárias Animais / Neoplasias Mamárias Experimentais Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transformação Celular Neoplásica / Quinases da Família src / Subunidade RIalfa da Proteína Quinase Dependente de AMP Cíclico / Glândulas Mamárias Animais / Neoplasias Mamárias Experimentais Limite: Animals / Female / Humans Idioma: En Ano de publicação: 2015 Tipo de documento: Article